Analysis of serious adverse events

A recent paper documented underreporting of safety data in published randomized controlled trials (RCTs).1 Serious adverse events (SAEs) are one component of safety and are potentially the most important outcome measure in RCTs. Regulatory bodies require data on SAEs to be collected in all clinical trials. Serious adverse events include any untoward medical occurrences that result in death, are life-threatening, require hospitalization o